Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 5Fatigue 5Breast Neoplasms 5Anxiety Disorders 3Lung Neoplasms 2Uterine Neoplasms 1Substance-Related Disorders 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Psychological Well-Being 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasm Regression, Spontaneous 1Multiple Myeloma 1Lymphoma 1Leukemia 1Glioblastoma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Cognitive Dysfunction 1Chronic Pain 1Caregiver Burden 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Lovastatin 3Deoxycholic Acid 3AZD 6244 3pirfenidone 2Vinblastine 2Transcranial Direct Current Stimulation 2Sirolimus 2Polidocanol 2Lasers, Solid-State 2Inhalation 2Acetylcysteine 2tipifarnib 1pomalidomide 1peginterferon alfa-2b 1mirdametinib 1diphenylcyclopropenone 1binimetinib 1X-Rays 1Vincristine 1Temozolomide 1Surveys and Questionnaires 1Sunitinib 1Specimen Handling 1Sorafenib 1Saline Solution 1Ranibizumab 1Radiotherapy 1Photons 1Pharmacokinetics 1Neuropsychological Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurofibromatosis 1 × Acceptance and Commitment Therapy × Clear all
NCT02471339 2022-06-14

Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
66 enrolled 17 charts
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡